Cargando…
LRRK2 Kinase Activity Does Not Alter Cell-Autonomous Tau Pathology Development in Primary Neurons
BACKGROUND: Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson’s disease (PD) and are also associated with genetic risk in idiopathic PD. Mutations in LRRK2, including the most common p.G2019S lead to elevated kinase activity, making LRRK2 kinase inhibi...
Autores principales: | Henderson, Michael X., Changolkar, Lakshmi, Trojanowski, John Q., Lee, Virginia M.Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461695/ https://www.ncbi.nlm.nih.gov/pubmed/33720852 http://dx.doi.org/10.3233/JPD-212562 |
Ejemplares similares
-
LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons
por: Henderson, Michael X., et al.
Publicado: (2018) -
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
por: Henderson, Michael X., et al.
Publicado: (2019) -
Human tau pathology transmits glial tau aggregates in the absence of neuronal tau
por: Narasimhan, Sneha, et al.
Publicado: (2019) -
Unique pathological tau conformers from Alzheimer’s brains transmit tau pathology in nontransgenic mice
por: Guo, Jing L., et al.
Publicado: (2016) -
LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice
por: Henderson, Michael X., et al.
Publicado: (2019)